Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Handbook of Experimental Pharmacology
|
March 25, 2023
Human iPS Cells for Clinical Applications and Cellular Products
Moyra Lawrence
Emerging Topics in Life Sciences
|
February 1, 2021
Using genome editing to engineer universal platelets
Moyra Lawrence, Annett Mueller, Cedric Ghevaert
Trends in Genetics : TIG
|
December 26, 2015
Lateral Thinking: How Histone Modifications Regulate Gene Expression
Moyra Lawrence, Sylvain Daujat, Robert Schneider
Wellcome Open Research
|
August 1, 2019
ZMYM2 inhibits NANOG-mediated reprogramming
Moyra Lawrence, Thorold W Theunissen, Patrick Lombard, et al.
NPJ Regenerative Medicine
|
May 27, 2021
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP
Moyra Lawrence, Amanda Evans, Thomas Moreau, et al.
Science Advances
|
February 16, 2022
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
Moyra Lawrence, Arash Shahsavari, Susanne Bornelöv, et al.
Blood Advances
|
April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors
Amanda L Evans, Amanda Dalby, Holly R Foster, et al.
Nature
|
February 12, 2013
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency
Yael Costa, Junjun Ding, Thorold W Theunissen, et al.
Haematologica
|
March 12, 2026
Thyroid hormones induce an acute platelet release mechanism via integrin αVβ3
Holly R Foster, Nina Herbert, Christian A Di Buduo, et al.
Blood
|
January 20, 2022
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia
Cavan Bennett, Moyra Lawrence, Jose A Guerrero, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Handbook of Experimental Pharmacology
|
March 25, 2023
Human iPS Cells for Clinical Applications and Cellular Products
Moyra Lawrence
Emerging Topics in Life Sciences
|
February 1, 2021
Using genome editing to engineer universal platelets
Moyra Lawrence, Annett Mueller, Cedric Ghevaert
Trends in Genetics : TIG
|
December 26, 2015
Lateral Thinking: How Histone Modifications Regulate Gene Expression
Moyra Lawrence, Sylvain Daujat, Robert Schneider
Wellcome Open Research
|
August 1, 2019
ZMYM2 inhibits NANOG-mediated reprogramming
Moyra Lawrence, Thorold W Theunissen, Patrick Lombard, et al.
NPJ Regenerative Medicine
|
May 27, 2021
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP
Moyra Lawrence, Amanda Evans, Thomas Moreau, et al.
Science Advances
|
February 16, 2022
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
Moyra Lawrence, Arash Shahsavari, Susanne Bornelöv, et al.
Blood Advances
|
April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors
Amanda L Evans, Amanda Dalby, Holly R Foster, et al.
Nature
|
February 12, 2013
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency
Yael Costa, Junjun Ding, Thorold W Theunissen, et al.
Haematologica
|
March 12, 2026
Thyroid hormones induce an acute platelet release mechanism via integrin αVβ3
Holly R Foster, Nina Herbert, Christian A Di Buduo, et al.
Blood
|
January 20, 2022
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia
Cavan Bennett, Moyra Lawrence, Jose A Guerrero, et al.
Page
of 1